1. Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma
    Melina Mitsiogianni et al, 2020, European Journal of Nutrition CrossRef
  2. Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells
    Shreepa J. Chauhan et al, 2020, International Journal of Molecular Sciences CrossRef
  3. MicroRNA heterogeneity in melanoma progression
    Anita Thyagarajan et al, 2019, Seminars in Cancer Biology CrossRef
  4. Forkhead box O1 promotes INS-1 cell apoptosis by reducing the expression of CD24
    YUHANG MA et al, 2016, Molecular Medicine Reports CrossRef
  5. From chemo-prevention to epigenetic regulation: The role of isothiocyanates in skin cancer prevention
    Melina Mitsiogianni et al, 2018, Pharmacology & Therapeutics CrossRef
  6. Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
    Anita Thyagarajan et al, 2018, International Journal of Molecular Sciences CrossRef
  7. UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment
    Timothy C. Frommeyer et al, 2022, Frontiers in Immunology CrossRef
  8. Effects of miRNA-149-5p and Platelet-Activating Factor-Receptor Signaling on the Growth and Targeted Therapy Response on Lung Cancer Cells
    Shreepa J. Chauhan et al, 2022, International Journal of Molecular Sciences CrossRef
  9. Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy
    I A da Silva-Jr et al, 2017, Oncogenesis CrossRef
  10. MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention
    Anita Thyagarajan et al, 2018, Journal of Pharmacology and Experimental Therapeutics CrossRef
  11. The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents
    null Mitsiogianni et al, 2019, Antioxidants CrossRef
  12. Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy
    Ildefonso Alves da Silva Junior et al, 2018, Clinics CrossRef
  13. Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth
    Eric Romer et al, 2018, International Journal of Molecular Sciences CrossRef